Global Markets Direct Market Research Reports

TITLE Actions
Impetigo (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Impetigo (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Drugs In Development, 2021, provides an overview of the Impeti...

Tuberculosis (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Tuberculosis (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Drugs In Development, 2021, provides an overview of th...

Aspergillosis (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Aspergillosis (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Drugs In Development, 2021, provides an overview of ...

Cryptosporidiosis (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Cryptosporidiosis (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptosporidiosis - Drugs In Development, 2021, provides an over...

Malaria (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Malaria (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an overview of the Malaria ...

Leishmaniasis (Kala-Azar) (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Leishmaniasis (Kala-Azar) (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis - Drugs In Development, 2021, provides an ...

Hepatitis B (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Hepatitis B (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Drugs In Development, 2021, provides an overview of the ...

Cytomegalovirus (HHV-5) Infections (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Cytomegalovirus (HHV-5) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus Infections - Drugs In Developme...

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 13 molecules. Out of w...

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Drugs in Development, 2021 Summary Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Protein kinase C (PKC) is an enzyme belonging...

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Drugs in Development, 2021 Summary According to the recently published report 'Complement C5 - Drugs In Development, 2021'; Complement...

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Drugs in Development, 2021 Summary Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 18 molecules. Out of which approximately 16 molecu...

Catenin Beta 1 (Beta Catenin or CTNNB1) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Catenin Beta 1 (Beta Catenin or CTNNB1) - Drugs in Development, 2021 Summary Catenin Beta 1 (Beta Catenin or CTNNB1) - Catenin beta-1 or ?-catenin is a protein that is encoded by the CTNNB1 gene. In the presence of Wnt ligan...

Glycoprotein 41 (gp41) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Glycoprotein 41 (gp41) - Drugs in Development, 2021 Summary According to the recently published report 'Glycoprotein 41 - Drugs In Development, 2021'; Glycoprotein 41 (gp41) pipeline Target constitutes close to 18 molecules....

20s Proteasome - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

20s Proteasome - Drugs in Development, 2021 Summary 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institu...

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - C-C chemokine rec...

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Drugs in Development, 2021 Summary According to the recently published report 'C5a Anaphylatoxin Chemotactic Receptor 1 - Drugs In Development, 2021'; C5a Anaphylato...

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Drugs in Development, 2021 Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 21...

Glucagon Like Peptide 2 Receptor (GLP2R) - Drugs in Development, 2021
Published in Sep 2021 | US $ 3500 Onwards | By Global Markets Direct

Glucagon Like Peptide 2 Receptor (GLP2R) - Drugs in Development, 2021 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-co...

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Drugs In Development, 2021
Published in Aug 2021 | US $ 3500 Onwards | By Global Markets Direct

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Drugs In Development, 2021 Summary Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) pipeline Target constitutes close to 8 molecules. The latest report...

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: DEC20

Connect for special KNOWLEDGE STORE Deals
Subscription starts at $ 20K